Nationally Recommended Vaccines

National Childhood Immunisation Schedule

The National Childhood Immunisation Schedule (NCIS) comprises childhood vaccinations recommended as the standard of care for protection against vaccine preventable diseases that are of significant healthcare burden to Singapore or would be so without these vaccinations. 

In consultation with the Expert Committee on Immunisation (ECI), MOH regularly reviews vaccination policies and inclusion of vaccines into the schedule, taking into consideration local disease burden, vaccine safety, efficacy and cost effectiveness of the vaccines. This ensures that the national recommendations for childhood vaccination are up to date. 

Currently, the NCIS covers vaccinations against 12 diseases – tuberculosis, hepatitis B, diphtheria, tetanus, pertussis, poliovirus, Haemophilus influenzae type b, measles, mumps, rubella, pneumococcal disease and human papillomavirus. From 1 November 2020, the NCIS will also cover vaccinations against two more diseases, i.e. varicella (chickenpox) and influenza.

Of these, vaccinations against measles and diphtheria are compulsory for children under the Infectious Diseases Act.

D1, D2, D3: Dose 1, Dose 2, Dose 3

B1, B2: Booster 1, Booster 2

10-11, 12-13, 13-14 years: Primary 5, Secondary 1, Secondary 2 (Tdap, IPV, HPV (for females) and MMR (as catch-up) vaccines are provided as part of Health Promotion Board’s school-based vaccination programme)

MMR: Only the dose 2 is recommended to be given as part of the MMRV vaccine

Hep B: Doses 2 and 3 are recommended to be given as part of the 6-in-1 vaccine at 2 and 6 months, respectively

Click here to download the PDF version of the NCIS 

National Adult Immunisation Schedule

The National Adult Immunisation Schedule (NAIS) was established in November 2017 to provide guidance on vaccinations that persons age 18 years or older should adopt to protect themselves against vaccine-preventable diseases.

Certain adults are at increased risk of complications or susceptible to vaccine preventable diseases if they have not previously received the vaccination and are in contact with individuals who have the infection. Vaccinations recommended under the NAIS aim to prevent such infections among susceptible individuals and reduce complications, morbidity and mortality.

The NAIS was developed based on international best practice and the recommendations of the Expert Committee on Immunisation (ECI). Considerations include: 

• local disease burden;
• age, occupation, pre-existing medical conditions, vaccination history; 
• vaccine safety, efficacy and cost effectiveness of the vaccines in preventing infections among susceptible individuals and reducing complications, morbidity and mortality.

The vaccines in the NAIS protect against the following 11 diseases – Influenza, pneumococcal disease, human papillomavirus, tetanus, diphtheria, pertussis, measles, mumps, hepatitis B, and varicella (chickenpox).